OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The Role of Glutamate Underlying Treatment-resistant Depression
Jeongseop Kim, Tae-Eun Kim, Seung‐Hwan Lee, et al.
Clinical Psychopharmacology and Neuroscience (2023) Vol. 21, Iss. 3, pp. 429-446
Open Access | Times Cited: 13
Jeongseop Kim, Tae-Eun Kim, Seung‐Hwan Lee, et al.
Clinical Psychopharmacology and Neuroscience (2023) Vol. 21, Iss. 3, pp. 429-446
Open Access | Times Cited: 13
Showing 13 citing articles:
Esketamine reduces postoperative depression in breast cancer through TREK-1 channel inhibition and neurotransmitter modulation
Jiachi Xu, M Li, Yu Hu, et al.
Cancer Cell International (2025) Vol. 25, Iss. 1
Open Access | Times Cited: 1
Jiachi Xu, M Li, Yu Hu, et al.
Cancer Cell International (2025) Vol. 25, Iss. 1
Open Access | Times Cited: 1
Treatment of Depression in Huntington’s Disease: A Systematic Review
Shayan Abdollah Zadegan, Frank Ramirez, Kirthan S. Reddy, et al.
Journal of Neuropsychiatry (2024)
Closed Access | Times Cited: 6
Shayan Abdollah Zadegan, Frank Ramirez, Kirthan S. Reddy, et al.
Journal of Neuropsychiatry (2024)
Closed Access | Times Cited: 6
The Patient’s Perspective on the Effects of Intranasal Esketamine in Treatment-Resistant Depression
Maria Pepe, Giovanni Bartolucci, Ilaria Marcelli, et al.
Brain Sciences (2023) Vol. 13, Iss. 10, pp. 1494-1494
Open Access | Times Cited: 11
Maria Pepe, Giovanni Bartolucci, Ilaria Marcelli, et al.
Brain Sciences (2023) Vol. 13, Iss. 10, pp. 1494-1494
Open Access | Times Cited: 11
Role of Glial Cells and Receptors in Schizophrenia Pathogenesis
Yousef Tizabi, Marta C. Antonelli, Daniela Tizabi, et al.
Neurochemical Research (2025) Vol. 50, Iss. 2
Closed Access
Yousef Tizabi, Marta C. Antonelli, Daniela Tizabi, et al.
Neurochemical Research (2025) Vol. 50, Iss. 2
Closed Access
Is there a risk of esketamine misuse in clinical practice?
Carlos Roncero, M. Merizalde Torres, Néstor Szerman, et al.
Therapeutic Advances in Drug Safety (2025) Vol. 16
Open Access
Carlos Roncero, M. Merizalde Torres, Néstor Szerman, et al.
Therapeutic Advances in Drug Safety (2025) Vol. 16
Open Access
β-Hydroxybutyrate ameliorated metabolic dysfunction and improved synaptic integrity via AKT signaling in an LPS-induced depression mice model
Shengnan Mou, Tahir Ali, Ling Li, et al.
Food Bioscience (2025), pp. 106513-106513
Closed Access
Shengnan Mou, Tahir Ali, Ling Li, et al.
Food Bioscience (2025), pp. 106513-106513
Closed Access
Patient Experience with Intranasal Esketamine in Treatment-Resistant Depression: Insights from a Multicentric Italian Study (REAL-ESKperience)
Marco Di Nicola, Maria Pepe, Giacomo d’Andrea, et al.
Journal of Personalized Medicine (2025) Vol. 15, Iss. 4, pp. 161-161
Open Access
Marco Di Nicola, Maria Pepe, Giacomo d’Andrea, et al.
Journal of Personalized Medicine (2025) Vol. 15, Iss. 4, pp. 161-161
Open Access
Heart Rate Variability as a Potential Predictor of Response to Intranasal Esketamine in Patients with Treatment-Resistant Depression: A Preliminary Report
Lorenzo Moccia, Giovanni Bartolucci, Maria Pepe, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 16, pp. 4767-4767
Open Access | Times Cited: 3
Lorenzo Moccia, Giovanni Bartolucci, Maria Pepe, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 16, pp. 4767-4767
Open Access | Times Cited: 3
Synaptotagmin-4 induces anhedonic responses to chronic stress via BDNF signaling in the medial prefrontal cortex
Jeongseop Kim, Sihwan Seol, Taeeun Kim, et al.
Experimental & Molecular Medicine (2024) Vol. 56, Iss. 2, pp. 329-343
Open Access | Times Cited: 2
Jeongseop Kim, Sihwan Seol, Taeeun Kim, et al.
Experimental & Molecular Medicine (2024) Vol. 56, Iss. 2, pp. 329-343
Open Access | Times Cited: 2
Very Low-Dose Sublingual Ketamine for Borderline Personality Disorder and Treatment-Resistant Depression
Mitchell B. Liester, Rachel Wilkenson, Barry Patterson, et al.
Cureus (2024)
Open Access | Times Cited: 1
Mitchell B. Liester, Rachel Wilkenson, Barry Patterson, et al.
Cureus (2024)
Open Access | Times Cited: 1
Identification of Key Genes and Imbalanced SNAREs Assembly in the Comorbidity of Polycystic Ovary Syndrome and Depression
Yi Cao, Weijing Wang, Xuxia Song, et al.
Genes (2024) Vol. 15, Iss. 4, pp. 494-494
Open Access | Times Cited: 1
Yi Cao, Weijing Wang, Xuxia Song, et al.
Genes (2024) Vol. 15, Iss. 4, pp. 494-494
Open Access | Times Cited: 1
GluN2A: a promising target for developing novel antidepressants
Gang Wang, Qi Wang, Qiu-Hua Liu, et al.
The International Journal of Neuropsychopharmacology (2024) Vol. 27, Iss. 9
Open Access | Times Cited: 1
Gang Wang, Qi Wang, Qiu-Hua Liu, et al.
The International Journal of Neuropsychopharmacology (2024) Vol. 27, Iss. 9
Open Access | Times Cited: 1
Glutamate concentrations related to depression and mania symptoms in patients with G raves' disease: A 1H ‐magnetic resonance spectroscopy study
Shih‐Hsien Lin, Po See Chen, Shih‐Ming Huang, et al.
The Kaohsiung Journal of Medical Sciences (2024) Vol. 40, Iss. 8, pp. 770-772
Open Access
Shih‐Hsien Lin, Po See Chen, Shih‐Ming Huang, et al.
The Kaohsiung Journal of Medical Sciences (2024) Vol. 40, Iss. 8, pp. 770-772
Open Access
Pharmacovigilance of esketamine nasal spray: an analysis of the FDA adverse event reporting system database
Ruixue Liu, Chunxiao Liu, Dianwei Feng, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access
Ruixue Liu, Chunxiao Liu, Dianwei Feng, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access
